MIT: New Blood-testing Device Can Quickly Spot Cancer Cells, HIV

A Harvard bioengineer and an MIT aeronautical engineer have created a new device that can detect single cancer cells in a blood sample, potentially allowing doctors to quickly determine whether cancer has spread from its original site. The microfluidic device, described in the March 17 online edition of the journal Small, is about the size […]
Continue reading…

 

Doctors See More Children With Inflammatory Bowel Disease

Once a medical rarity in children, inflammatory bowel disease today is increasingly common in kids, but many of them may not be diagnosed in a timely manner, according to experts from the Pediatric Inflammatory Bowel Disease Center at Johns Hopkins Children’s. Gastroenterologists there say that many of the hundreds of children they see were referred […]
Continue reading…

 

New Hemoglobin Monitor May Help Guide Transfusion Decisions

A spectrophotometric hemoglobin (SpHb) sensor may become a useful new approach to noninvasive monitoring of blood hemoglobin levels during surgery, reports a study in the April issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS). The SpHb technology could reduce the need for invasive monitoring or the need for blood […]
Continue reading…

 

UK Scientists Move Closer To Discovering Cause Of Alzheimer’s

UK scientists have taken another step forward in their search to identify the causes of Alzheimer’s. Important research which sheds new light on one of the key building blocks of the disease was presented at an Alzheimer’s Society research roadshow in Southampton last Thursday. Dr Amritpal Mudher from Southampton University was speaking about her findings […]
Continue reading…

 

Proteomics Research Heading Towards Personalized Treatments For Cancer, Diabetes And Inflammatory Diseases

NeoProteomics Inc., a biomarker development and software company, has secured an exclusive option agreement with Case Western Reserve University. The deal has potential to enhance various forms of treatment of cancer, diabetes, and inflammatory diseases. Proteomics is the scientific next step in vital research of protein structures of biological systems. NeoProteomics, founded in 2006 in […]
Continue reading…

 

Now, a one-hour operation to change heart valve!

London: An Indian-origin surgeon-led team in Britain has come up with a one-hour keyhole operation to replace heart valve, a breakthrough which offers hope to cardiac patients too sick to undergo an open-heart surgery. Vinayak Bapat of Guy’s and St Thomas’ Hospital and his team have developed the procedure, called transcatheter aortic valve implantation (TAVI), […]
Continue reading…

 

A Host DNA-Repair Pathway Required For HIV Integration

The human immunodeficiency virus (HIV), the cause of AIDS, makes use of the base excision repair pathway when inserting its DNA into the host-cell genome, according to a new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. Crippling the […]
Continue reading…

 

Carey Anders, MD, UNC Physician-Scientist Receives Grant To Study Breast Cancer Brain Metastases

The American Association for Cancer Research (AACR) has announced that Carey Anders, MD, assistant professor of medicine and a member of UNC Lineberger Comprehensive Cancer Center will receive a Breast Cancer Research Foundation-AACR Grant for Translational Breast Cancer Research. The $181,000 grant will be presented at the organization’s 102nd Annual Meeting, to be held in […]
Continue reading…

 

Eskimo study suggests fish oils curb diseases

Washington: A study of Alaska’s Yup’ik Eskimos, who consume 20 times more omega-3 fats from fish than most Americans, suggests these oils can prevent obesity-related illness such as diabetes and heart disease, researchers said Friday. The researchers analyzed data from 330 people living in the Yukon Kuskokwim Delta region of southwest Alaska. Although 70 percent […]
Continue reading…

 

New Perspectives On Cancer And The Immune System

In a new review article published in yesterday’s special section of Science focusing on the past forty years since the U.S. declared “War on Cancer,” three Cancer Research Institute scientists describe how advances in the field of tumor immunology have revealed a complex and paradoxical relationship between cancer and the immune system, and discuss how […]
Continue reading…

 

How mutations in a gene cause Parkinson’s disease

Washington: Scientists have found a way that mutations in a gene called LRRK2 may cause the most common inherited form of Parkinson’s disease. The study, conducted by researchers at Mount Sinai School of Medicine, shows that upon specific modification called phosphorylation, LRRK2 protein binds to a family of proteins called 14-3-3, which has a regulatory […]
Continue reading…

 

Novel Spinal Neuromodulation Device Delivers Significant Pain Relief To Low Back Pain Patients

Results from an ongoing prospective study report that a novel spinal neuromodulation device changes the paradigm for patients suffering with low back pain who have not found relief through conventional spinal cord stimulation (SCS). The single-centered results from this ongoing, multi-centered study were presented at the American Academy of Pain Medicine’s 27th Annual Meeting. The […]
Continue reading…

 

Asthma drug could help fight Alzheimer’s disease

Washington: Researchers at Temple University’s School of Medicine have found that a drug used to treat asthma can reduce the formation of amyloid beta, a peptide in the brain that is implicated in the development of Alzheimer’s disease. In previous studies, the Temple researchers discovered that 5-lipoxygenase, an enzyme long known to exist in the […]
Continue reading…

 

Approval Of New Melanoma Therapy Changes Landscape For Patients

Thirteen years of waiting is now over for melanoma patients. That’s how long it’s been since the last therapy became available to treat the most lethal form of skin cancer melanoma. The FDA announced approval of Yervoy, an immunotherapy treatment for advanced melanoma. The drug will be used to treat melanoma patients whose cancer has […]
Continue reading…